DBVT
DBV Technologies S.A.
Key Financials
EPS (Diluted)
$-1.05
↑ 10.3%
Net Income
$-146947000
↓ 29.0%
Operating Income
$-147056000
↓ 26.1%
Shareholders' Equity
$168.8M
↑ 516.2%
Total Assets
$233.7M
↑ 256.0%
Revenue
$5.6M
↑ 35.8%
Long-term Debt
$510000.00
↓ 59.7%
Total Liabilities
$64.9M
↑ 69.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/5/2026 | View on SEC |
| S-8 | 6/4/2026 | View on SEC |
| 8-K | 6/3/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| SCHEDULE 13G/A | 5/12/2026 | View on SEC |
| ARS | 5/11/2026 | View on SEC |
| DEF 14A | 5/11/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DBVT |
| Company Name | DBV Technologies S.A. |
| CIK | 1613780 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | I0 |
| Phone | 33(0)155427878 |